SINGAPORE, Oct 16 (Bernama-BUSINESS WIRE) — MUST Connect 2023 Singapore, a roadshow that helps Korean life science startups expand overseas by connecting them with global pharmaceutical companies and investors, was held on Oct. 11 (Wed.) and 12 (Thu.) at Singapore Science Park.
Twelve Korean startups showcased their innovative products and solutions at the event. Among them were Neurophet, which uses AI to analyze brain structures that vary from person to person; ImmunAbs, an autoimmune treatment that is set to enter Phase II clinical trials in the U.S. next year; and ABLELabs, a manufacturer of bio-lab liquid handling robots that won second place in the Innovator’s Pitch Challenge at RESI Boston September. Seoul Biohub, a South Korean government-backed organization, provided support to some of the participating companies.
http://mrem.bernama.com/viewsm.php?idm=47257